Cart
sales@molnova.com
MK-8617
CAS No. 1187990-87-9
MK-8617( MK 8617 | MK8617 )
Catalog No. M10644 CAS No. 1187990-87-9
A potent, orally active pan-inhibitor of HIF prolyl hydroxylase (HIF-PHD) with IC50 of 1.0,1.0, and 14 nM for HIF-PHD1, 2, and 3, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 38 | In Stock |
|
| 10MG | 65 | In Stock |
|
| 25MG | 141 | In Stock |
|
| 50MG | 231 | In Stock |
|
| 100MG | 384 | In Stock |
|
| 200MG | 548 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMK-8617
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, orally active pan-inhibitor of HIF prolyl hydroxylase (HIF-PHD) with IC50 of 1.0,1.0, and 14 nM for HIF-PHD1, 2, and 3, respectively.
-
DescriptionA potent, orally active pan-inhibitor of HIF prolyl hydroxylase (HIF-PHD) with IC50 of 1.0,1.0, and 14 nM for HIF-PHD1, 2, and 3, respectively; shows no significant inhibition on the cytochrome p450 enzymes; exhibits good oral bioavailability, causes increases in circulating reticulocytes in mice and has potential for treatment of anemia.
-
In Vitro——
-
In Vivo——
-
SynonymsMK 8617 | MK8617
-
PathwayAngiogenesis
-
TargetHIF/HIF Prolyl-hydroxylase
-
RecptorPHD1|PHD2|PHD3|PHD1,PHD2,PHD3
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number1187990-87-9
-
Formula Weight443.45
-
Molecular FormulaC24H21N5O4
-
Purity>98% (HPLC)
-
SolubilityDMSO: 16 mg/mL (36.1 mM) （ < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESCOC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC)NC(=O)C3=CN=C(NC3=O)C4=NN=CC=C4
-
Chemical NameN-[Bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Debenham JS, et al. J Med Chem. 2016 Dec 22;59(24):11039-11049.
molnova catalog
related products
-
PT-2399
PT-2399 (PT 2399, PT2399)?is a selective, potent HIF-2α antagonist that binds directly to the HIF2α PAS B domain.
-
HIF-1α-IN-2
HIF-1α-IN-2 is a novel and highly potent HIF-1α inhibitor with anticancer and antitumor activity that inhibits the expression of HIF-1α and VEGF in a dose-dependent manner and inhibits cell migration.
-
HIF-2α agonist 2
HIF-2α agonist 2 is an HIF-2α agonist with an EC50 value of 1.68 μM for HIF-2α. HIF-2α agonist 2 can promote the stability of the ARNT A/B ring in the 3z structure of HIF-2a-ARNT complex without cytotoxicity to 786-o-Reha-Luc cells.
